The researchers discovered that after just six months of use, patients had double the risk of developing neovascular ...

The Wall Street Journal reports on the expected FDA approval of lenacapavir and what it might mean for Gilead's future in the market. Other coverage of science and research-related news is on a ...

A cheap over-the-counter supplement could hold the key to preventing heart failure in people with Type 2 diabetes, according ...

A newly published randomized controlled trial in Frontiers in Medicine has found that the practice of Transcendental ...

New data from the CONFIDENCE trial demonstrates that combination therapy with finerenone and empagliflozin leads to ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.